Literature DB >> 18677455

[Complaints of patients with dysphonia].

K Glas1, U Hoppe, U Eysholdt, A Weber, F Rosanowski.   

Abstract

BACKGROUND: In this study, the problems and difficulties experienced by German-speaking voice patients were assessed using a structured questionnaire.
METHODS: A total of 54 patients, 30 women and 24 men, aged 48.5+/-15.8 years suffering from benign organic and functional voice disorders, underwent systematic phoniatric examination including a detailed interview about the voice problem. The same procedure was applied to 56 age and gender matched normal control persons.
RESULTS: There were no significant gender or diagnosis-related differences concerning the number and type of symptoms and symptom-related complaints (p>0.05). Most patients (88.9%) felt disturbed by their voice problem in a total of 118 different daily situations.
CONCLUSIONS: The way patients experience voice disorders does not depend on the origin of the disorder and not on the gender. The data allow the conclusion that the case history of dysphonic patients can be assessed by a structured voice interview.

Entities:  

Mesh:

Year:  2008        PMID: 18677455     DOI: 10.1007/s00106-008-1808-9

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  16 in total

1.  A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS).

Authors:  P H Dejonckere; P Bradley; P Clemente; G Cornut; L Crevier-Buchman; G Friedrich; P Van De Heyning; M Remacle; V Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-02       Impact factor: 2.503

2.  Voice-related quality of life in organic and functional voice disorders.

Authors:  Thorsten Rasch; Susanne Günther; Ulrich Hoppe; Ulrich Eysholdt; Frank Rosanowski
Journal:  Logoped Phoniatr Vocol       Date:  2005       Impact factor: 1.487

3.  Quality of life in dysphonic patients.

Authors:  Sylvia Krischke; Susan Weigelt; Ulrich Hoppe; Volker Köllner; Michael Klotz; Ulrich Eysholdt; Frank Rosanowski
Journal:  J Voice       Date:  2005-03       Impact factor: 2.009

4.  [Determination of subjective impairment in dysphonia. A methodological comparison].

Authors:  S Günther; T Rasch; M Klotz; U Hoppe; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

5.  Patient-reported problems associated with dysphonia.

Authors:  S Scott; K Robinson; J A Wilson; K Mackenzie
Journal:  Clin Otolaryngol Allied Sci       Date:  1997-02

6.  Assessing outcomes for dysphonic patients.

Authors:  M S Benninger; A S Ahuja; G Gardner; C Grywalski
Journal:  J Voice       Date:  1998-12       Impact factor: 2.009

7.  The quality of life impact of dysphonia.

Authors:  J A Wilson; I J Deary; A Millar; K Mackenzie
Journal:  Clin Otolaryngol Allied Sci       Date:  2002-06

Review 8.  Quality-of-life impact of non-neoplastic voice disorders: a meta-analysis.

Authors:  Seth M Cohen; William D Dupont; Mark S Courey
Journal:  Ann Otol Rhinol Laryngol       Date:  2006-02       Impact factor: 1.547

9.  [Voice handicap in patients with organic and functional dysphonia].

Authors:  S Weigelt; S Krischke; M Klotz; U Hoppe; V Köllner; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

10.  Developing core sets for patients with head and neck cancer based on the International Classification of Functioning, Disability and Health (ICF).

Authors:  U Tschiesner; A Cieza; S N Rogers; J Piccirillo; G Funk; G Stucki; A Berghaus
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-14       Impact factor: 3.236

View more
  1 in total

1.  Throat related symptoms and voice: development of an instrument for self assessment of throat-problems.

Authors:  Roland Rydell; Jacqueline Eriksson; Lucyna Schalén; Viveka Lyberg-Åhlander
Journal:  BMC Ear Nose Throat Disord       Date:  2010-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.